| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/22/2008 | US20080119515 Heterocyclic Kinase Inhibitors: Methods of Use and Synthesis |
| 05/22/2008 | US20080119514 6-(2,4-dinitrophenylazo)-2,5,7,8-tetramethyltridecyl))-1,2,3,4-tetrahydroquinoline; to treat cell proliferative diseases |
| 05/22/2008 | US20080119513 To treat osteoarthritis; matrix metalloproteinases-13 inhibitors |
| 05/22/2008 | US20080119512 Carboxamide Derivatives as Therapeutic Agents |
| 05/22/2008 | US20080119511 such as 3-(2-Methyl-2H-1,2,4-triazol-3-yl)-3-[4-(4'-trifluoromethyl-biphenyl-3-ylmethoxy)-phenyl]-propionic acid; G-protein coupled receptor modulator; antidiabetic and hypoglycemic agent; non-insulin dependent diabetes, obesity, hyperglycemia, glucose intolerance, hypertension, cardiovascular disease |
| 05/22/2008 | US20080119510 Substituted Imidazo [4,5-B] Pyridines As Inhibitors Of Gastric Acid Secretion |
| 05/22/2008 | US20080119509 Nontoxic; asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), eosinophilic granuloma, psoriasis |
| 05/22/2008 | US20080119508 Multi-Route Administration Of Immune Response Modifier Compounds |
| 05/22/2008 | US20080119507 Novel Isoindole Derivatives, Compositions Containing Same, Preparation Thereof and Pharmaceutical Uses Thereof in Particular as Inhibitors of Chaperone Protein HSP90 Activities |
| 05/22/2008 | US20080119506 5-methylamino-11-ethylidene-5,6,9,10-tetrahydro-7-methyl-5,9-methanocycloocta[b]pyridin-2(1H)-one; acetylcholine esterase iinhibitor; analgesic, cognition activator; migraines, functional or organic pain syndrome, autoimmune diseases; easy permeation through the blood-brain barrier, long duration |
| 05/22/2008 | US20080119505 (4aR,10bR)-6-(2,6-Dimethoxy-pyridin-3-yl)-8,9-dimethoxy-1,2,3,4,4a,10b-hexahydro-phenanthridine; phosphodiesterase inhibitor; airway obstructions, antiinflammatory agent, antidepressant; dermatoses, eczema, lupus, rheumatoid arthritis, osteoarthritis, AIDS, multiple sclerosis, graft versus host reaction |
| 05/22/2008 | US20080119504 aporphine 10- and 11-mono-esters and 10,11-asymmetric di-esters; dopaminergic agonist; Parkinson's disease, hemicrania, restless leg syndrome, sexual dysfunction, hyperprolactemia and psychotic disorders |
| 05/22/2008 | US20080119503 Androgen receptor modulators and methods of use thereof |
| 05/22/2008 | US20080119502 Vinca derivatives |
| 05/22/2008 | US20080119501 Immediate release oxymorphone compositions and methods of using same |
| 05/22/2008 | US20080119500 Pyridine imidazoles and aza-indoles as progesterone receptor modulators |
| 05/22/2008 | US20080119499 2-(4'-Methoxy-biphenyl-4-yl)-3-(4-methoxymethyl-phenyl)-but-2-enedinitrile; stilbene Donor-Acceptor-Donor compounds in non linear optics including chromophoric optical medium of a 3-dimensional optical memory; strong 2-photon absorbance that undergo photoinduced isomerization processes |
| 05/22/2008 | US20080119498 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazole, trans-4-[4-(4-fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazole-1-yl]cyclohexanol, 4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole; eye ointment |
| 05/22/2008 | US20080119497 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones |
| 05/22/2008 | US20080119496 7-Substituted Purine Derivatives for Immunosuppression |
| 05/22/2008 | US20080119495 Phosphodiesterase 4 inhibitors |
| 05/22/2008 | US20080119494 Drug-enhanced adhesion prevention |
| 05/22/2008 | US20080119492 anticarcinogenic agent; composition with guanine G-quadruplex spacer structure that fixing themselves to the O-quadruplex structure formed by the telomeres, thus inhibiting telomerase activity; regulate cell proliferation, anticarcinogenic agent; synergistic with other chemotherapeutic agents |
| 05/22/2008 | US20080119491 Amidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 05/22/2008 | US20080119490 Viral Polymerase Inhibitors |
| 05/22/2008 | US20080119489 Imidazole derivatives |
| 05/22/2008 | US20080119488 Modulators Of Nuclear Receptors |
| 05/22/2008 | US20080119487 Novel non-imidazole compounds |
| 05/22/2008 | US20080119486 Benzoyl-piperazine derivatives |
| 05/22/2008 | US20080119485 Novel Benzofurans and Indols |
| 05/22/2008 | US20080119484 Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 05/22/2008 | US20080119483 Synergistic combination of lipid synthesis inhibitors; no side effects; itraconazole or ketaconazole |
| 05/22/2008 | US20080119482 Administration of 1-[2-(4-(3-trifluoromethyl-phenyl)piperazin-1-yl)ethyl]-2,3-dihydro-1H-benzimidazol-2-one (flibanserin) |
| 05/22/2008 | US20080119481 CNS disorders; sexual disorders; 5-HT1A binding agent |
| 05/22/2008 | US20080119480 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 05/22/2008 | US20080119479 Antiangiogenic and/or vascular permeability reducing effect; cancer involving a solid tumor or chronic myelogenous leukemia |
| 05/22/2008 | US20080119478 2-(4-(4-(4-chlorophenyl)oxazol-2-yl)phenoxymethyl)-2-methyl-6-nitro-2,3-dihydroimidazo[2,1-b]oxazole; bactericide; excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria |
| 05/22/2008 | US20080119477 N-Biaryl and N-Arylheteroaryl Piperazine Derivatives as Modulators of the 5Ht2c Receptor Useful For the Treatment of Disorders Related Thereto |
| 05/22/2008 | US20080119476 Cetp Inhibitors |
| 05/22/2008 | US20080119475 comprises a folate receptor ligand capable of binding to activated macrophages or a vitamin/vitamin-receptor binding analog and immunogen, a cytotoxin, or another compound capable of altering macrophage function |
| 05/22/2008 | US20080119474 5,6-bis(4-methoxyphenyl)-2-ethyl-2H-pyridazin-3-one; interleukin-1 beta antagonist; collagenase inhibitor; analgesic, antiinflammatory, antiarthritic, antiischemic agents; autoimmune disease, rheumatic diseases; osteoporosis |
| 05/22/2008 | US20080119473 3-[4-(4-Fluoro-phenyl)-[1,3,5]triazin-2-yl]-benzoic acid; suppressing premature translation termination associated with nonsense mutation in an mRNA; diseases associated with nonsense mutations in mRNA; antiinflammatory, anticarcinogenic, antidiabetic agent; autoimmune, neurodegenerative diseases |
| 05/22/2008 | US20080119471 1-((4-chlorophenoxy)methyl)carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine; chemokine receptor CCR1 antagonist; chemokine (MIP-1 alpha and RANTES) inhibitor; antiinflammatory agent; multiple sclerosis, rheumatoid arthritis |
| 05/22/2008 | US20080119470 8-hydroxy-3H-quinazolin-4-(thi)one derivatives; ability to enter CNS, sequester transition metals Cu, Zn and Fe from various amiloid beta entities, reducing their toxicity; neurodegenerative disorders; Alzheimer's, Parkinson's, Cruetzfeldt-Jacob diseases, amyotrophic lateral sclerosis, cataract |
| 05/22/2008 | US20080119469 Novel Compounds |
| 05/22/2008 | US20080119468 Phthalazine, aza-and diaza-phthalazine compounds and methods of use |
| 05/22/2008 | US20080119467 Purine Derivatives, Compositions Containing Them and Use Thereof |
| 05/22/2008 | US20080119466 1-(4-Chloro-3-(trifluoro-methyl)phenyl)-3-(4-imidazo-[4,5-c]pyridin-1-ylphenyl)urea; Raf, a serine-threonine protein kinase inhibitor; Raf/MEK/ERK cascade in proliferation of human cancer cells; anticarcinogenic agent; psoriasis, atherosclerosis, chronic rheumatoid arthritis and diabetes |
| 05/22/2008 | US20080119465 Novel Indoline Compounds |
| 05/22/2008 | US20080119464 N-(4-piperidin-1-yl-phenyl)-2-[5-(thiaxolidine-3-carbonyl)-pyrrolidin-3-ylidene]-acetamide;antidiabetic agents; hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis |
| 05/22/2008 | US20080119463 4-Anilino-3-quinolinecarbonitriles for the treatment of acute myelogenous leukemia (AML) |
| 05/22/2008 | US20080119462 Method for treating vascular hyperpermeable disease |
| 05/22/2008 | US20080119461 N-(4,6-dimethyl-2-pyridinyl)-L-valyl-(4R) N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-4-((6-methoxy-1-isoquinolinyl)oxy)-L-prolinamide; viricide; synergistic with other active ingredients |
| 05/22/2008 | US20080119460 {2-Amino-4-[(4-(4-chlorophenyl)piperidin-1-yl)methyl]thiophen-3-yl}(4-chlorophenyl)methanone; analgesic, antidepressant; cardiac disease or disorder, neurological disease or injury, sleep disorder, epilepsy, neuropathic pain, angina |
| 05/22/2008 | US20080119459 Trifluoromethylbenzamide Derivatives and Therapeutic Uses Thereof |
| 05/22/2008 | US20080119458 N-substituted-azacyclylamines as histamine-3 antagonists |
| 05/22/2008 | US20080119457 2-Bromo-4-(1,5,5-trimethyl-7-oxo-4,5,6,7-tetrahydro-1H-indazol-3-yl)-benzonitrile; heat-shock protein 90 inhibitors; anticarcinogenic, antiinflammatory agent, angiogenesis inhibitor, fungicide; arthritis, ischemia, solid tumors, leukemia |
| 05/22/2008 | US20080119456 [2-benzhydryl-4-(4-chlorophenyl)-thiazol-5-yl]-acetic acid; Chemoattractant Receptor-homologous molecule expressed on T Helper cells type 2 ligand; antiallergen and antiinflammatory agent; asthma, rhinitis, allergic airway syndrome, allergic rhinobronchitis; Alzheimer's disease, rheumatoid arthritis |
| 05/22/2008 | US20080119455 {2-[3-(4-Methyl-2-[2-methypropoxy]phenyl)-ureido]-thiazol-4-yl}-acetic acid ethyl ester; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase |
| 05/22/2008 | US20080119454 Aryl carbonyl derivatives as therapeutic agents |
| 05/22/2008 | US20080119453 Bicyclic derivatives as modulators of ion channels |
| 05/22/2008 | US20080119452 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H, 1-benzopyran-2,4'-piperidine]; non-peptidic delta opioid receptor synergistic withother active ingredients; antidepressant, anxiolytic agent; Alzheimer's Disease, age-related cognitive decline, Parkinson's Disease, AIDS, schizophrenia |
| 05/22/2008 | US20080119451 N-(2-aminophenyl)-4-(3-methylpyridin-2-yl)benzamide; histone deacetylase (HDAC) and angiogenesis inhibitor; antiproliferative agent; solid tumor cancers, lymphomas, myelomas, melanomas; antiinflammatory agent; arthritis, psoriasis, multiple sclerosis, asthma |
| 05/22/2008 | US20080119450 Use of creatine or creatine analogs for the treatment of diseases of the nervous system |
| 05/22/2008 | US20080119449 Reducing the risk of osteoporotic bone fractures; kit |
| 05/22/2008 | US20080119448 Methods of treating an ocular allergy with low dose dexamethasone |
| 05/22/2008 | US20080119447 6-alkoxyalkyl estradiol derivatives and methods of use |
| 05/22/2008 | US20080119446 a steroidal quinol that is converted to a biologically active estrogen compound via enzyme catalyzed reduction; 2-(1-adamantyl)-estra-1,3,5(10)-triene-3,17 beta -diol; estrogen receptors activator; low lipid solubility; cataract, glaucoma, conjunctivitis, diabetic retinopathy |
| 05/22/2008 | US20080119445 Testing a woman's blood to make sure it includes estradiol within a predetermined range and testosterone within a second predetermined range, then administrating a drug selected from the group consisting of vardenafil hydrochloride and tadalafil prior to sexual activity; dehydroepiandrosterone (DHEA) |
| 05/22/2008 | US20080119444 Methods and compositions for the treatment of cancer |
| 05/22/2008 | US20080119443 Certain lithocholic acid analogues that inhibit sialyltransferase |
| 05/22/2008 | US20080119442 as hypoxia-selective drugs and radiosensitizers for cancer therapy; nitroreductase inhibitor; 1-(Chloromethyl)-5,6-dinitro-3-(5,6,7-trimethoxyindol-2-carbonyl)-1,2-dihydro-3H-benzo[e]indole; halogenation of naphthalene derivative followed by hydration and cyclization |
| 05/22/2008 | US20080119441 conditions with inhibited renal phosphate excretion, such as diabetes mellitus, hemodialysis with the progression of diabetic nephropathy, renal failure; [5-(4-Ethylbenzyl)-2-hydroxyphenyl]phosphonic acid; serum phosphate concentration-lowering activity; calcification inhibitor |
| 05/22/2008 | US20080119440 Combination with Bis(thiohydrazide amides) for treating cancer |
| 05/22/2008 | US20080119439 lipoxin A4 analogs; 13-(4-fluorophenoxy)-2,3,12-trihydroxytrideca-4,6,10-trien-8-ynyloxy)acetic acid; platelet activating and tumor necrosis factors antagonist; anti-neutrophil (PMN) agents which inhibit PMN chemotaxis; antiinflammatory agent; inflammatory bowel, Crohn's diseases, ulcerative colitis |
| 05/22/2008 | US20080119438 medium molecular weight heparin ranging from 6,000 Daltons to 12,000 Daltons composition, has sufficient length to bridge antithrombin to thrombin, comprising a mixture of sulfated oligosaccharides; treating cardiovascular diseases, preventing the formation of a thrombus, arterial/deep vein thrombosis |
| 05/22/2008 | US20080119437 Hyaluronate compositions |
| 05/22/2008 | US20080119436 increasing the sensitivity of a cell or tissues to cytotoxic cancer therapy with a naturally occurring nucleic acids |
| 05/22/2008 | US20080119435 Hes6 as a marker of pancreatic endocrine cells |
| 05/22/2008 | US20080119434 Sir2a-based therapeutic and prophylactic methods |
| 05/22/2008 | US20080119433 administering an isolated polynucleotide encoding a nucleic acid or a polypeptide in the skin cells; improve skin thickness, wrinkle, tones, eleasticity, texture, coloring and aging resistance |
| 05/22/2008 | US20080119432 Inhibition Of Metallo-Beta-Lactamase By Rna |
| 05/22/2008 | US20080119431 cyclic oligosaccharides has amine function groups attached through C6 position, for DNA transfer, cell permeation and improve drug intracellular delivery; biocompatibility and low toxicity; cyclodextrins connected through chains of alkylguanidines, tertiary nitrogen |
| 05/22/2008 | US20080119430 Compositions and Methods for Angiogenesis-Related Molecules and Treatments |
| 05/22/2008 | US20080119429 Methods and means for increasing resistance to cell damage |
| 05/22/2008 | US20080119428 Method For Diagnosing Non-Small Cell Lung Cancers By Trna-Dihydrouridine Synthase Activity Of Urlc8 |
| 05/22/2008 | US20080119425 administering biodrug oligonucleotide anticarcinogenic agents for treating breast cancer, prostate cancer, bladder cancer, ovarian cancer, lung cancer, renal cancer, melanoma, and pancreatic cancer; gene expression inhibition |
| 05/22/2008 | US20080119424 biodrugs contains siRNA or vector encoding siRNA, including a retinoid as antitumor agents, anticarcinogenic agents |
| 05/22/2008 | US20080119423 isolated antisense oligonucleotide hybrids for treating pain in a mammal; biodrugs |
| 05/22/2008 | US20080119422 antidiabetic agents; 4-chloro-3-(4-ethylphenylmethyl)-1-( beta -D-glucopyranosyl)indole; hypoglycemic agent, wound healing agent, antilipemic agents, hypotensive agent; chemical synthesis with a chemical intermediates |
| 05/22/2008 | US20080119421 producing a synchronized cells by administering a cell cycle arresting drug, then adding a microtubule stabilizing drug, and applying mechanical vibrational energy ultrasound; drug deliverying anticarcinogenic agent directed to be more toxic to cancer cells than normal cells |
| 05/22/2008 | US20080119420 plant extracts triterpene saponins has anti-inflammatory and analgesic activity; solvent extraction and chromatography separation; 3-O- beta -D-glucopyranosyl (1 --> 2)- beta -D-xylopyranosyl-urs-12,18-dien-28-oic acid 28-O- beta -D-glucopyranosyl ester; antiinflammatory agents |
| 05/22/2008 | US20080119419 Bifunctional heterocyclic compounds and methods of making and using same |
| 05/22/2008 | US20080119418 C-9 alkenylidine bridged macrolides |
| 05/22/2008 | US20080119417 Metabolic Syndrome-Improving Agent and Medicine, Supplement, Functional Food and Food Additive Containing the Same |
| 05/22/2008 | US20080119416 pregnane or androstane steroids for use in methods of prevention, alleviation or treatment of CNS disorders, nervous system disorders |
| 05/22/2008 | US20080119415 Therapy and prophylaxis of infectious disease, autoimmune disease or allergic condition by administering monophosphoryl lipid a (mpl) and a l-seryl aminoalkyl glucosaminide phosphate compound (agp) |
| 05/22/2008 | US20080119413 a mixture of an alk(en)ylpolyglycoside such as a decylglucoside, polyquaternium-10 as quaternized cellulose polymer, a thickener selected from guar gums, celluloses, hydroxyethyl cellulose; air incorporated in above mixture |
| 05/22/2008 | US20080119412 Polypeptides for Modulating Binding of Trp Channel Proteins and Trp- Associated Proteins |
| 05/22/2008 | US20080119408 Pth formulations for intranasal delivery |